China Dev
   DEVELOPMENT  |  FINANCE  |  TECHNOLOGY  |  EDUCATION  |  SOCIETY  |  SPORTS  |  AsiaDev
     
C H I N A -- R S S
2point6billion
All Roads Lead to China
Awakening China
bluechina
Catching Mice In China
Chinalyst
China Briefing
China Business Blog
China Crossroads
China CSR
China Dialogue
China Economics Blog
China Economic Review
China Environment Law
China Environment News
China Financial Markets
China Hearsay
China Knowledge
China Law Blog
China Law Practice
China National News
China Post
China Sourcing Blog
China Stakes
China Stocks Blog
ChinaTechNews.com
China Vortex
Danwei
Experience Not Logic
Imagethief
Lost Laowai
Managing The Dragon
Ogilvy China
PanAsiaBiz
People's Daily
Phayul
randomwire.com
Shanghai Daily
Sinomania
The Other End of China
+ add a blog
A S I A -- R S S
Mongolia Web
News On Japan
Taiwan News
Taiwan Headlines
Inquirer
New Straits Times
Channel NewsAsia
The Star
Jakarta Post
Antara
New Nation
Business Standard
The Hindu
Business Line
Rediff
merinews
Daily Mirror
Eurasianet
Radio Free Europe
Pacific Magazine
Islands Business
Pacific News Center
Fiji Times
Fiji Live
Asia Times
Asianews.it
The Economist
Business Times
Business Week
New York Times
BBC
CNN
IHT
ADB (publications)
ADB (news)
World Bank (E.Asia)
World Bank (S.Asia)
USAID
BIS (all updates)
BIS (papers)
OECD
UNICEF
WFP
WEF
WHO
WWF
NZAID
ReliefWeb
IRIN
Add to My Yahoo! 
World Health Organization
WHO news
This channel provides the five most recent WHO news articles.



WHO welcomes Swissmedic approval of Ebola vaccine trial at Lausanne University Hospital (Oct 28)
The World Health Organization (WHO) welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). This marks the latest step towards bringing safe and effective Ebola vaccines for testing and implementation as quickly as possible.

Approval means that the vaccine can be used on approximately 120 individuals in Lausanne. The trial, which is receiving support from WHO, is the latest in a series of trials that are ongoing in Mali, the United Kingdom, and the United States.


WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine (Oct 24)
WHO convened a meeting with high-ranking government representatives from Ebola-affected countries and development partners, civil society, regulatory agencies, vaccine manufacturers and funding agencies yesterday to discuss and agree on how to fast track testing and deployment of vaccines in sufficient numbers to impact the Ebola epidemic.

WHO was called upon by all parties to ensure coordination between the various actors.


Mali confirms its first case of Ebola (Oct 24)
Mali’s Ministry of Health has confirmed the country’s first case of Ebola virus disease. The Ministry received positive laboratory results, from PCR testing, on Thursday and informed WHO immediately. In line with standard procedures, samples are being sent to a WHO-approved laboratory for further testing and diagnostic work.

In telephone conversation on Thursday night, health officials gave WHO the following details about the case, which is currently undergoing intense investigation.


Statement on the 3rd meeting of the IHR Emergency Committee regarding the 2014 Ebola outbreak in West Africa (Oct 23)
The third meeting of the Emergency Committee convened by the WHO Director-General under the IHR 2005 regarding the 2014 Ebola virus disease (EVD, or “Ebola”) outbreak in West Africa was conducted with members and advisors of the Emergency Committee on Wednesday, 22 October 2014, from 13:00 to 17:10 CET.

This meeting was convened in advance of the 3-month date of the expiration of the temporary recommendations issued on 8 August 2014 and their extension on 22 September 2014, owing to the increase in numbers of cases in Guinea, Liberia, and Sierra Leone, and the new exportation of cases resulting in limited transmission in Spain and United States of America.


Summary report of a WHO High-level meeting on ebola vaccines access and financing (Oct 23)
A high-level emergency meeting, convened by WHO at the request of several governments and representatives of the pharmaceutical industry, was held on 23 October to look at the many complex policy issues that surround eventual access to experimental Ebola vaccines.

Ways to ensure the fair distribution and financing of these vaccines were discussed in an atmosphere characterized by a high sense of urgency. This sense of urgency was conveyed in many ways – from plans for the different phases of clinical trials to be performed concurrently rather than consecutively, to suggested partnerships for expediting clinical trials, to proposals for getting all development partners moving in tandem and at the same accelerated pace.
   CONTACT US  |  RSS |  AsiaDev |  NewsOnVietnam |  NewsOnJapan Copyright © 2008, ChinaDev.org